Text-size

Cover image for Bad pharma
ISBN#9780865478008
BIB ID#1618717
Call# 615.1072 G

Bad pharma

0
Author
Publisher
New York : Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, 2013.
Subjects
Description
pages cm
Summary
Intro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data. Argues that doctors are deliberately misinformed by profit-seeking pharmaceutical companies who withhold information about drug efficacy and side effects, explaining pharmaceutical data manipulation and its consequences.

Reviews and Notes

Summary/Annotation ->  We like to imagine that medicine is based on evidence and the results of fair testing and clinical trials. In reality, those tests and trials are often profoundly flawed. We like to imagine that doctors who write prescriptions for everything from antidepressants to cancer drugs to heart medication are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators have some code of ethics and let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct in the medical industry affects us on a global scale. With Goldacre's characteristic flair and a forensic attention to detail, Bad Pharma reveals a shockingly broken system and calls for regulation. This is the pharmaceutical industry as it has never been seen before.

Availability

LocationCall NumberItem TypeVolumeBarcodeStatussort icon
Seaside615.1072 GAdult Hard Cover0228565644025In Transit
Broad Channel615.1072 GAdult Hard Cover0228564673918Due 8-11-2014
Flushing615.1072 GAdult Hard Cover0228567903999Available
Hollis615.1072 GAdult Hard Cover0228567902512Available
Elmhurst615.1072 GAdult Hard Cover0228564771373Available
Middle Village615.1072 GAdult Hard Cover0228564673728Available
Central Adult Non-Fiction615.1072 GAdult Hard Cover0228564684386Available
Lefrak City615.1072 GAdult Hard Cover0228561478113Available
East Flushing615.1072 GAdult Hard Cover0228564684287Available

Marc Record

01919cam a22004098i 4500
001
vtls001618717
003
NJQ
005
20130111092400.0
008
121226s2013 nyu b 001 0 eng
010
 
 
$a 2012-038902
020
 
 
$a 9780865478008 (hbk.) : $c $28.00
020
 
 
$a 0865478007
039
 
9
$a 201301110924 $b mjacobs $c 201301030906 $d ymok $y 201212261136 $z jlin $w ANFJan13.dat $x 104
040
 
 
$a DLC $b eng $c DLC $e rda $d NjBwBT
082
 
 
$a 615.1072/4 $2 23
099
 
 
$a 615.1072 G
100
1
 
$a Goldacre, Ben.
245
1
 
$a Bad pharma : $b how drug companies mislead doctors and harm patients / $c Ben Goldacre.
250
 
 
$a First American edition.
260
 
 
$a New York : $b Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, $c 2013.
300
 
 
$a pages cm
336
 
 
$a text $2 rdacontent
337
 
 
$a unmediated $2 rdamedia
338
 
 
$a volume $2 rdacarrier
504
 
 
$a Includes bibliographical references and index.
505
 
 
$a Intro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data.
520
 
 
$a Argues that doctors are deliberately misinformed by profit-seeking pharmaceutical companies who withhold information about drug efficacy and side effects, explaining pharmaceutical data manipulation and its consequences.
599
 
 
$a A Jan13
650
 
 
$a Drugs $x Testing.
650
 
 
$a Drugs $x Testing $x Moral and ethical aspects.
650
 
 
$a Clinical trials $x Moral and ethical aspects.
650
 
 
$a Pharmaceutical industry $x Moral and ethical aspects.
650
 
 
$a Drugs $x Quality control.
654
 
 
$2 BISAC $a SCIENCE / Research & Methodology^MEDICAL / Pharmacology^MEDICAL / Ethics
995
 
 
$a YMOK/MJACOBS-CC:0113
999
 
 
$a VIRTUA
999
 
 
$a VTLSSORT0080 0100 0200 0201 0400 0820 0990 1000 2450 2500 2600 3000 3360 3370 3380 5040 5050 5200 5990 6500 6501 6502 6503 6504 6540 9950 9992